Erik Roberson retweeted
New publication from @AlectorTx & @RobersonLabUAB describing MoA & target engagement for #Latozinemab (AL001), now in Ph3 trials for #GRN-FTD. Blocking the sortilin-PGRN interaction Grn+/- mice rescued the hets' social dominance phenotype in tube test. rdcu.be/deUTl
Erik Roberson retweeted
Headed to beautiful San Diego for #SfN22 . Stoked to share all of my PhD work with @RobersonLabUAB on Monday afternoon! Stop by poster G26 for a great discussion and some small-molecule drug development for #Alzheimer 's disease therapeutics.
Erik Roberson retweeted
Tremendous thanks to Alzheimer's of Central Alabama Junior Board for supporting the Lindy Harrell Predoctoral Scholars program at @uab_neurology and @UAB_Alzheimers — Congratulations to 2022 Scholars @HBDeanMSTP from @RobersonLabUAB and @IanMatt82085005 from @constanza343 lab
Erik Roberson retweeted
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders. Plasma NfL can aid in participant selection for prevention or early treatment trials. bit.ly/3t1qOUO
@RobersonLabUAB @JulioCRojas10 @MC_Tartaglia @allftd
Erik Roberson retweeted
Introducing our newest #ScientistSpotlight Shreya Kashyap (@snkash)! She is a 4th year Neuro MD-PhD student in the Roberson Lab. She has been a leader in health equity here at UAB and is currently the president of @AAWSMUAB.
Erik Roberson retweeted
We are recruiting clinical investigators (MD and/or PhD) for the Estes Endowed Professorship in #Alzheimer's disease. Join our rapidly expanding and highly collaborative group in the UAB ADRC. Apply by 12/1 for priority review. uab.peopleadmin.com/postings…
Erik Roberson retweeted
Join us tomorrow for the next Mini Medical School tomorrow at 6 p.m.
Anyone is welcome to attend! Sign up: bit.ly/2Rg6EmH
Erik Roberson retweeted
Jonathan Roth, a 5th year Neuro @UAB_GBS student, is our August #ScientistSpotlight. Swipe to read more about Jonathan, who was recently awarded the 2021 GBS Mentorship and Teaching Award. Follow Jonathan @JRothUAB. #stemeducation #scientist
Erik Roberson retweeted
Join us Tuesday, Aug. 31 from 6-7 p.m. to hear what Alabama’s leading neurological experts have to say about Alzheimer’s and its future in our families.
Visit go.uab.edu/mini-medical-scho… to learn more and register.
Erik Roberson retweeted
1/ #NeuroTwitter check out this 🧵 to learn more about ✨The University of Alabama Neurology Residency Program✨
Program: UAB Neurology
Location: Birmingham, AL
Website: uab.edu/medicine/neurology/e…
Twitter: @uabneurores
Instagram: @uabneurores
Erik Roberson retweeted
Delivering progranulin to neuronal lysosomes protects against excitotoxicity, new from the Arrant lab sciencedirect.com/science/ar…
Erik Roberson retweeted
Using @i2b2 to mine enterprise-wide clinical data for understanding #disparities in #Alzheimers — led by @CF_Murch @uabSOPH @UABRadiology @uab_neurology #NIAfundedADRC pubmed.ncbi.nlm.nih.gov/3333…
Erik Roberson retweeted
In the early stages of #Alzheimers, dynamically acquired amyloid PET data enable estimating the likelihood of tau PET positivity — led by @UABMSTP student Fabio Raman in collaboration with @WUADRC @tlsmit1 @UABRadiology @uab_neurology #NIAfundedADRC jnm.snmjournals.org/content/…
Erik Roberson retweeted
Gene therapy offers hope for persons with genetic diseases. A webinar Thursday, Dec. 3 tells what gene therapy is, how it works, and discusses an FTD clinical trial. #EndFTD Register now! bit.ly/3qgtHyj
Erik Roberson retweeted
Are you an early career researcher interested in AD and neuroscience? Register for free and submit your abstract! Excited to be on the organizing committee discussing Emerging Concepts sessions with @TweetwithQuinn, @lindsay__alex, and @btlamb today!
Lead the way to what's next in neuroscience. We are now accepting abstracts for the first-ever AAIC Neuroscience Next. Neuroscience students and early career investigators are invited to submit by Sept. 21. Learn more: alz.org/NeuroscienceNext. #AAICNeuro #ENDALZ
Erik Roberson retweeted
We're now part of the network of @NIH-funded Alzheimer’s Disease Research Centers as a new exploratory ADRC.
nia.nih.gov/news/nih-expands…
Erik Roberson retweeted
Excited to share my new preprint on #DravetSyndromeAwarenessDay on non-coding variant causing DS through poison exon inclusion - collaboration between @RobersonLabUAB and @GregBarsh. Thank you, @jNickCochran and Greg Cooper at @hudsonalpha @curedravet
biorxiv.org/content/10.1101/…
Erik Roberson retweeted
Excited to share @RobersonLabUAB's preprint on AD risk gene BIN1 driving Tau-dependent network hyperexcitability. Thank you to @DayLabUAB and @LLMcMahonNeuro labs for an excellent collaboration!
Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability biorxiv.org/cgi/content/shor… #biorxiv_neursci
Erik Roberson retweeted
Although the microtubule stabilizer TPI-287 had adverse effects, the innovative basket design of this trial we conducted with @UCSFmac proved useful for detecting differential effects in various tauopathies (#Alzheimer, PSP, corticobasal syndrome)
Basket design clinical trials improve efficiency of tau therapeutic development by simultaneous testing in tau-related neurodegeneration syndromes ja.ma/2Q7aKOJ
Erik Roberson retweeted
Science is hard, but super fun when you have these awesome people to share it with! Congratulations to Shreya Kashyap @snkash on winning the poster award at the UAB Aging Symposium! #BestLabOnCampus @RobersonLabUAB






























